Dasatinib Sandoz 20 mg filmom obložene tablete
| Name | Dasatinib Sandoz 20 mg filmom obložene tablete |
|---|---|
| Marketing Authorisation Number | HR-H-291161273 |
| Active Substance | dasatinib |
| Composition | svaka filmom obložena tableta sadrži 20 mg dasatiniba |
| Pharmaceutical Form | filmom obložena tableta |
| Manufacturer | Lek Pharmaceuticals d.d., Ljubljana, Slovenija Remedica Ltd., Limassol, Cipar |
| Marketing Authorisation Holder | Sandoz d.o.o., Maksimirska 120, Zagreb, Hrvatska |
| Marketing Authorisation Date | 17.02.2023 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/22-02/167 |
| Registration Number | 381-12-01/70-23-05 |
| Prescription | na recept |
| Type of prescription | ograničeni recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | L01EA02 |
| Medicinal product marketed in the Croatia | Ne |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
